IL6 and COVID-19: Systemic inflammation with increased synthesis of IL-6, as well as interferon-γ, IL-1β, IL-33 and TNF, is the basis of the progressive course of COVID-19 and seriously affects erythropoiesis through various mechanisms supported in part by abnormal iron metabolism [4].